현대 정신의학은 어떻게 우울증을 이해하고 있나?

키워드

참고문헌 (64)

1. American Psychiatric Association, "DSM-IV-TR Text Revision: Diagnostic and Statistical Manual for Mental Disorders, 4th ed" (2000), American Psychiatric Press
2. Rush AJ, "The varied clinical presentations of major depressive disorder", J Clin Psychiatry, 8, pp.4~10 (2007)
3. Leventhal AM, "The empirical status of melancholia: implications for psychology", Clin Psychol Rev, pp.25~44 (2005)
4. Rush AJ, "xDexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression", Biol Psychiatry, 41, pp.915~928 (1997)
5. Rush AJ, "DSM-IV mood disorders: final overview ; DSM-IV Sourcebook, vol 4", pp.1019~1033 (1998), American Psychiatric Press
6. Ohayon MM, "Prevalence of depressive episodes with psychotic features in the general population", Am J Psychiatry, 159, pp.1855~1861 (2002)
7. Coryell W, "Psychotic depression", J Clin Psychiatry, 57(3), pp.27~31 (1996)
8. Fleming SK, "Neuropsychological correlates of psychotic features in major depressive disorder: a review and meta-analysis", J Psychiatr Res, 38, pp.27~35 (2004)
9. Gomez RG, "The neuropsychological profile of psychotic major depression and its relation to cortisol", Biol Psychiatry, 60, pp.472~478 (2006)
10. Dannon PN, "Current and emerging somatic treatment strategies in psychotic major depression", Expert Rev Neurother, 6, pp.73~80 (2006)
11. Wijkstra J, "Pharmacological treatment for psychotic depression", Cochrane Database Syst Rev (2005)
12. Fava M, "Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder", STAR*D. Psychol Med, 34, pp.1299~1308 (2004)
13. Russell JM, "Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression", Depress Anxiety, 13, pp.18~27 (2001)
14. Ramana R, "Remission and relapse in major depression: a two-year prospective follow-up study", Psychol Med, 25, pp.1161~1170 (1995)
15. Thase ME, "Recognition and diagnosis of atypical depression", J Clin Psychiatry, 68(8), pp.11~16 (2007)
16. Rosenthal NE, "Effects of light treatment on core body temperature in seasonal affective disorder", Biol Psychiatry, 27, pp.39~50 (1990)
17. Terman M, "On the question of mechanism in phototherapy for seasonal affective disorder: considerations of clinical efficacy and epidemiology", J Biol Rhythms, 3, pp.155~172 (1988)
18. Kasper S, "Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland", Arch Gen Psychiarty, 46, pp.823~833 (1989)
19. Sohn CH, "Update on the biology of seasonal affective disorder", CNS Spectr, 10, pp.635~646 (2005)
20. Golden RN, "The efficacy of light therapy in the treatment of mood disorder: a review and meta-analysis of the evidence", Am J Psychiatry, 162, pp.656~662 (2005)
21. Bloch M, "Risk factors associated with the development of postpartum mood disorders", J Affect Disord, 88, pp.9~18 (2005)
22. Park SS, "Psychosocial risk factors of postpartum depression", Korean J Psychosomatic Medicine, 7, pp.124~133 (1999)
23. Chaudron LH, "relationship between postpartum psychosis and bipolar disorder: a review", J Clin Psychiatry, 64, pp.1284~1292 (2003)
24. Weissman MM, "Wickramaratne P, Prusoff BA. Early-onset major depression in patients and their children", J Affect Disord, 15, pp.269~277 (1988)
25. Klein DN, "A family study of major depressive disorder in a community sample of adolescents", Arch Gen Psychiatry, 58, pp.13~20 (2001)
26. Kovacs M, "Suicidal behaviors and childhoodonset depressive disorders: a longitudinal investigation", J Am Acad Child Adolesc Psychiatry, 32, pp.8~20 (1993)
27. Kessler RC, "Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.593~602 (2005)
28. 이상혁, "노년기 우울증과 스트레스", 스트레스 硏究, 15(4), pp.295~301 (2007), 대한스트레스학회
29. Keller MB, "Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression", Biol Psychiatry, 44, pp.348~360 (1998)
30. Gilmer WS, "Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project", Acta Psychiatr Scand, 112, pp.425~433 (2005)
31. Khan A, "Severity of depression and response to antidepressant and placebo: an analysis of the Food and Drug Administration database", J Clin Psychopharmacol, 22, pp.40~45 (2002)
32. Kessler RC, "Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey", Br J Psychiatry Suppl, 30, pp.17~30 (1996)
33. Wilhelm K, "The relationship between interpersonal sensitivity, anxiety disorders and major depression", J Affect Disord, 79, pp.33~41 (2004)
34. Overbeek T, "Comorbidity of obsessive- compulsive disorder and depression: prevalence, symptom severity, and treatment effect", J Clin Psychiatry, 63, pp.1106~1112 (2002)
35. Fineberg NA, "Comorbid depression in obsessive compulsive disorder (OCD): symptomatic differences to major depressive disorder", J Affect Disord, 87, pp.327~330 (2005)
36. Brady KT, "Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress", Am J Psychiatry, 162, pp.1483~1493 (2005)
37. Breslau N, "Major depression and stages of smoking. A longitudinal investigation", Arch Gen Psychiatry, 55, pp.161~166 (1998)
38. Thase ME, "The role of Axis II comorbidity in the management of patients with treatment-resistant depression", Psychiatr Clin North Am, 19, pp.287~309 (1996)
39. Siris SG, "Depression in schizophrenia: perspective in the era of “Atypical” antipsychotic agents", Am J Psychiatry, 157, pp.1379~1389 (2000)
40. Whitehead C, "Antidepressants for the treatment of depression in people with schizophrenia: a systematic review", Psychol Med, 33, pp.589~599 (2003)
41. Austin MP, "Targeted group antenatal prevention of postnatal depression: a review", Acta Psychiatr Scand, 107, pp.244~250 (2003)
42. Porter RJ, "Neurocognitive impairment in drug-free patients with major depressive disorder", Br J Psychiatry, 182, pp.214~220 (2003)
43. Demyttenaere K, "The many faces of fatigue in major depressive disorder", Int J Neuropsychopharmacol, 8, pp.93~105 (2005)
44. Egeland J, "Asbjornsen A, Lund A, et al. Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance", Acta Psychiatr Scand, 108, pp.275~284 (2003)
45. Drevets WC, "Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression", Prog Brain Res, 126, pp.413~431 (2000)
46. Sarter M, "Choline transporters, cholinergic transmission and cognition", Nat Rev Neurosci, 6, pp.48~56 (2005)
47. Lyketsos CG, "Diagnosis and treatment of depression in Alzheimer’s disease. A practical update for the clinician", Dement Geriatr Cogn Disord, 17, pp.55~64 (2004)
48. Alexopoulos GS, "Executive dysfunction, heart disease burden, and remission of geriatric depression", Neuropsychopharmacology, 29, pp.2278~2284 (2004)
49. Bartolini M, "Motivational symptoms of depression mask preclinical Alzheimer’s disease in elderly subjects", Dement Geriatr Cogn Disord, 19, pp.31~36 (2005)
50. Boivin DB, "Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders", J Psychiatry Neurosci, 25, pp.446~458 (2000)
51. Mayeux R, "Behavioral manifestations of movement disorders. Parkinson’s and Huntington’s disease", Neurol Clin, 2, pp.527~540 (1984)
52. Bosboom JL, "Cognitive dysfunction and dementia in Parkinson's disease", J Neural Transm, 111, pp.1303~1315 (2004)
53. Björntorp P, "Do stress reactions cause abdominal obesity and comorbidities?", Obes Rev, 2, pp.73~86 (2001)
54. Miller GE, "Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease", J Psychosom Res, 59, pp.231~236 (2005)
55. Otte C, "Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study", Biol Psychiatry, 56, pp.241~247 (2004)
56. Kennedy SH, "Sexual dysfunction before antidepressant therapy in major depression", J Affect Disord, 56, pp.201~208 (1999)
57. Montgomery SA, "Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction", J Affect Disord, 69, pp.119~140 (2002)
58. Raison CL, "Neuropsychiatric adverse effects of interferon-alpha: recognition and management", CNS Drugs, 19, pp.105~123 (2005)
59. Capuron L, "Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and", or interferon-alpha cancer therapy, 2004, pp.18, 205~213
60. McWilliams LA, "Depression and anxiety associated with three pain conditions: results from a nationally representative sample", Pain, 111, pp.77~83 (2004)
61. Onder G, "Association between pain and depression among older adults in Europe: results from the Aged in Home Care (AdHOC) project: a cross-sectional study", J Clin Psychiatry, 66, pp.982~988 (2005)
62. Breslau N, "Headache and major depression: is the association specific to migraine?", Neurology, 54, pp.308~313 (2000)
63. Seok JH, "The conditional and characteristic factors of patients with major depressive disorder examined with clinical scales", Korean NeuroPsychiatric Association The Great Autumn Conference, pp.198~ (2006)
64. Lee SH, "The relationship between treatment response with clinical variables in major depressive disorder", Korean NeuroPsychiatric Association The Great Autumn Conference, pp.199~ (2006)

관련 논문AI추천